Annual Total Long Term Liabilities
$27.16 M
+$27.16 M+100.00%
December 31, 2021
Summary
- As of February 9, 2025, BIOT annual total long term liabilities is $27.16 million, with the most recent change of +$27.16 million (+100.00%) on December 31, 2021.
- During the last 3 years, BIOT annual total long term liabilities has risen by +$27.16 million (+100.00%).
Performance
BIOT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$9.70 M
-$492.80 K-4.84%
September 30, 2022
Summary
- As of February 9, 2025, BIOT quarterly total long term liabilities is $9.70 million, with the most recent change of -$492.80 thousand (-4.84%) on September 30, 2022.
- Over the past year, BIOT quarterly long term liabilities has dropped by -$10.50 million (-51.98%).
Performance
BIOT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BIOT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -52.0% |
| 3 y3 years | +100.0% | +100.0% |
| 5 y5 years | +100.0% | +100.0% |
BIOT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -64.3% | at low |
| 5 y | 5-year | at high | -100.0% | -64.3% | -100.0% |
| alltime | all time | at high | -100.0% | -64.3% | -100.0% |
Biotech Acquisition Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $9.70 M(-4.8%) |
| Jun 2022 | - | $10.19 M(-50.5%) |
| Mar 2022 | - | $20.60 M(-24.1%) |
| Dec 2021 | $27.16 M | $27.16 M(+34.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $20.19 M(-15.0%) |
| Jun 2021 | - | $23.76 M(+24.1%) |
| Mar 2021 | - | $19.15 M(>+9900.0%) |
| Dec 2020 | $0.00 | - |
| Sep 2020 | - | $0.00 |
FAQ
- What is Biotech Acquisition annual total long term liabilities?
- What is the all time high annual total long term liabilities for Biotech Acquisition?
- What is Biotech Acquisition annual total long term liabilities year-on-year change?
- What is Biotech Acquisition quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Biotech Acquisition?
- What is Biotech Acquisition quarterly long term liabilities year-on-year change?
What is Biotech Acquisition annual total long term liabilities?
The current annual total long term liabilities of BIOT is $27.16 M
What is the all time high annual total long term liabilities for Biotech Acquisition?
Biotech Acquisition all-time high annual total long term liabilities is $27.16 M
What is Biotech Acquisition annual total long term liabilities year-on-year change?
Over the past year, BIOT annual total long term liabilities has changed by +$27.16 M (+100.00%)
What is Biotech Acquisition quarterly total long term liabilities?
The current quarterly long term liabilities of BIOT is $9.70 M
What is the all time high quarterly long term liabilities for Biotech Acquisition?
Biotech Acquisition all-time high quarterly total long term liabilities is $27.16 M
What is Biotech Acquisition quarterly long term liabilities year-on-year change?
Over the past year, BIOT quarterly total long term liabilities has changed by -$10.50 M (-51.98%)